Sigma Aldrich

St. Louis, United States Founded: 1951 • Age: 75 yrs Acquired By Merck
Biochemical and organic chemicals are developed for scientific research applications.

About Sigma Aldrich

Sigma Aldrich is a Healthcare company based in St. Louis (United States) founded in 1951 by Alfred Bader, and was acquired by Merck in September 2014. It operates as a biochemical and organic chemicals are developed for scientific research applications. The company has 4,709 employees. Sigma Aldrich has completed 9 acquisitions, including Ace Animals, BioReliance and Cerilliant. Its chief executive is Udit Batra. Its website sigmaaldrich.com draws about 4.4 million monthly visits.

Company details

Sigma Aldrich was founded in 1951 in St. Louis, United States, within the chemicals sector. Biochemical and organic chemicals, along with related kits, are produced for applications in scientific research such as genomics, proteomics, biotechnology, and pharmaceutical development. Components are supplied for pharmaceutical, diagnostic, and manufacturing processes. Contract development and manufacturing services are provided for small and large molecules, leveraging bioprocess expertise.

  • Headquarters St. Louis, United States
  • Employees 4,709
  • Founders Alfred Bader
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Science and Education · Chemistry
  • Website sigmaaldrich.com/US/en
  • Social LinkedIn X
  • Acquired by Merck (Sep 2014)
Key Metrics
  • Annual Revenue
    $13.53 K (USD)
    0
    as on Dec 31, 2014
  • Net Profit
    $10.79 K (USD)
    109
    as on Dec 31, 2015
  • Investors
    Merck

    & 4 more

  • Employee Count
    4,709
  • Investments & Acquisitions
  • Acquired by
    Merck

    (Sep 2014)

Funding Insights of Sigma Aldrich

  • Total Rounds 24
  • First Round $850,000

    (Jul 2008)

  • Investors Count 4

Latest 10 of 24 funding rounds of Sigma Aldrich with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2024–Grant––
Mar 2022$49,495Grant––
Feb 2021$764,866Grant––
Dec 2019$18,375Grant––
Sep 2017$11,260Grant––
Feb 2017–Grant––
Jan 2017–Grant––
Jul 2016$22,344Grant––
Mar 2016$22,330Grant––
Feb 2016$16,932Grant––
Valuation history

5 investors in total: 5 institutional.

Investors in Sigma Aldrich

Sigma Aldrich has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include Merck, USAID and European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
-
–economie.gouv.fr-
Global poverty and development are addressed through USAID initiatives.
1961usaid.gov-
Scientific and technical information is managed and disseminated by OSTI.GOV.
–osti.govOak Ridge, United States
Merck is engaged in science and technology solutions globally.
1668merckgroup.comDarmstadt, Germany
Premium access

Investor details for Sigma Aldrich

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Sigma Aldrich

101 people are tracked at Sigma Aldrich (27 in leadership, 74 in team); the tracked headcount is 4,709.

NameRoleGroup
Alfred Bader
Co-FounderLeadership
Udit Batra
CEOLeadership
Michal Daniely
Director, Research & DevelopmentLeadership
Jean-Charles Wirth
Head of Applied SolutionsLeadership
David Hutchinson
General Counsel & Head of Legal Business PartnersLeadership
Melissa Stoneman
Director, Global Marketing CommunicationsLeadership
Karen Madden
Chief Technology OfficerLeadership
Paul Ross
Director Of R&d And Technology DevelopmentLeadership
Matthias Heinzel
CEOLeadership
Shaf Yousaf
Chief Marketing OfficerLeadership
Kasia Gralak McIpd
HR Business PartnerLeadership
James Wareham
Vice President -global Sales, Inventory & Operational PlanningLeadership
Bart Kerkman
Chief Information OfficerLeadership
Tim M. Jaeger
EVP & Chief Strategy & Transformation OfficerLeadership
Nelda Bonini
Head of Human Resources for Life ScienceLeadership
Gilles Fellous
Senior Director, IT Global ApplicationsLeadership
Mark Robillard
VP - R&dLeadership
Steve Cecil
Director Strategic Business Development - AnalyticalLeadership
Cheryl Stipsits
Environmental, Health & Safety Director - St. Louis OperationsLeadership
George Bleazard
Corporate Director - Ehs, Security, Transportation Compliance And Product SafetyLeadership

81 more people are available in the full profile.

Premium access

Complete people profiles for Sigma Aldrich

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Sigma Aldrich

Sigma Aldrich has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include Ace Animals, BioReliance and Cerilliant.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Developer of transfection reagents and electroporation products
mirusbio.comMadison, United States1995May 2024$600M
Developer of acoustic particle trapping systems for applications in research and public health
fdsonics.comWilbraham, United States2010Oct 2019β€’β€’β€’β€’
Energy generation and compliance services are provided by Fenix Power.
fenixpower.com.pe–2014Dec 2015β€’β€’β€’β€’
Biochemical reagents are manufactured for molecular biology and diagnostics.
resorg.comCleveland, United States1995Apr 2012β€’β€’β€’β€’
Biosafety testing, biomanufacturing, and toxicology services are offered to clients.
bioreliance.comRockville, United States1947Jan 2012$350M
Certified reference standards are manufactured for analytical and forensic uses.
cerilliant.comRound Rock, United States2009Dec 2010β€’β€’β€’β€’
Research rodents are bred and supplied to the biomedical sector.
aceanimals.comBerkshire County, United States1973Mar 2010β€’β€’β€’β€’
Solutions and services to aid research organizations identify and procure the chemistry they need for drug discovery and agrochemical research.
chemnavigator.comMilwaukee, United States1999Aug 2009β€’β€’β€’β€’
CDMO focussed mainly on vaccines and gene therapy products
molecularmed.comCarlsbad, United States1997May 2007β€’β€’β€’β€’
Premium access

Complete acquisition details for Sigma Aldrich

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Sigma Aldrich

13 dated milestones of Sigma Aldrich across 73 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sigma Aldrich is founded.
  2. Acquisition Acquires Molecular Medicine BioServices.
  3. Funding First funding round of $850K.
  4. Acquisition Acquires ChemNavigator.
  5. Acquisition Acquires Ace Animals.
  6. Acquisition Acquires Cerilliant.
  7. Acquisition Acquires BioReliance.
  8. Acquisition Acquires Research Organics.
  9. Exit Acquired by Merck.
  10. Acquisition Acquires Fenix ​​Power.
  11. Acquisition Acquires FloDesign Sonics.
  12. Funding Latest funding round, Grant,.
  13. Acquisition Acquires Mirus Bio.

Web traffic of Sigma Aldrich

The website of Sigma Aldrich (sigmaaldrich.com) receives about 4.4M visits a month and ranks #15,208 among all websites worldwide, #789 in Chemistry.

  • Monthly visits
    4.4M

    ▲ 8.4% vs previous month

  • Unique visitors
    1.8M

    per month

  • Global rank
    #15,208

    among all websites

  • Category rank
    #789

    Science and Education · Chemistry

Similar websites

Websites whose visitors overlap most with Sigma Aldrich. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
fishersci.com
100%
1.8M#30,987View details
tcichemicals.com
66%
–#60,674View details
merckmillipore.com
65%
691.2K#80,655View details
abcam.com
65%
602.8K#91,958View details
chemicalbook.com
chemicalbook.com
61%
–#35,490–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Sigma Aldrich

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

10 companies that operate in the same segment as Sigma Aldrich (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B–1,111
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.34 BUSD 301.49 M1,372
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Sigma Aldrich

Premium access

Complete news archive for Sigma Aldrich

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sigma Aldrich

Sigma Aldrich was founded in 1951 and raised its 1st funding round 57 years after it was founded.

Sigma Aldrich is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.

Udit Batra is the current CEO of Sigma Aldrich.

Sigma Aldrich has 4,709 employees.

Annual revenue of Sigma Aldrich is $13.53K as on Dec 31, 2014.

Sigma Aldrich was founded in 1951 in St. Louis, United States, within the chemicals sector. Biochemical and organic chemicals, along with related kits, are produced for applications in scientific research such as genomics, proteomics, biotechnology, and pharmaceutical development. Components are supplied for pharmaceutical, diagnostic, and manufacturing processes. Contract development and manufacturing services are provided for small and large molecules, leveraging bioprocess expertise.

Sigma Aldrich has made 9 acquisitions, including Ace Animals, BioReliance, and Cerilliant.

Sigma Aldrich has 5 investors. Key investors include Merck, USAID, European Union, Ministry of Economy, Finance and Industrial and Digital Sovereignty, and OSTI.GOV.

Yes. Sigma Aldrich was acquired by Merck in September 2014.

The website of Sigma Aldrich receives about 4.4 million visits a month and ranks #15,208 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available